Immunome (IMNM) Net Margin: 2023-2025
Historic Net Margin for Immunome (IMNM) over the last 2 years, with Jun 2025 value amounting to -1,157.61%.
- Immunome's Net Margin rose 53482.00% to -1,157.61% in Q2 2025 from the same period last year, while for Jun 2025 it was -1,784.14%, marking a year-over-year increase of 71295.00%. This contributed to the annual value of -3,382.37% for FY2024, which is 262045.00% down from last year.
- Latest data reveals that Immunome reported Net Margin of -1,157.61% as of Q2 2025, which was up 24.12% from -1,525.50% recorded in Q1 2025.
- Immunome's 5-year Net Margin high stood at -121.88% for Q3 2023, and its period low was -12,857.05% during Q1 2024.
- In the last 3 years, Immunome's Net Margin had a median value of -1,608.96% in 2025 and averaged -2,486.66%.
- Per our database at Business Quant, Immunome's Net Margin crashed by 1,266,792bps in 2024 and then spiked by 1,133,155bps in 2025.
- Immunome's Net Margin (Quarterly) stood at -2,421.17% in 2023, then slumped by 60,914bps to -3,030.31% in 2024, then soared by 53,482bps to -1,157.61% in 2025.
- Its last three reported values are -1,157.61% in Q2 2025, -1,525.50% for Q1 2025, and -3,030.31% during Q4 2024.